How semaglutide helps with weight loss: what the trials actually found

What the STEP 1 trial results really show

The cleanest way to understand what semaglutide does is to start with the numbers. STEP 1 randomised 1,961 adults with obesity (BMI 30 or above, or 27 with a weight-related condition) to either semaglutide 2.4mg weekly or placebo, both groups following diet and activity advice. After 68 weeks, the semaglutide group had lost an average of about 15% of starting body weight; the placebo group, roughly 2.4%. That gap is substantial, and it reflects a genuine biological effect rather than the diet advice alone.

You can read the full paper via the NEJM's STEP 1 publication. The key point is that the trial was tightly controlled: participants were tracked through dose increases, side-effect monitoring and regular contact. Real-world outcomes depend on the same discipline, steady titration, lifestyle changes alongside the medicine, and clinical oversight throughout.

The evidence base for semaglutide and weight loss goes beyond STEP 1; the STEP programme included trials in people with type 2 diabetes and cardiovascular risk, consistently showing meaningful reductions. But 15% at the 2.4mg maintenance dose is the figure most directly relevant to adults starting treatment for weight management.

The mechanism: why semaglutide slows appetite rather than just suppressing it

GLP-1 (glucagon-like peptide-1) is a hormone the gut releases naturally after you eat. It tells the brain you are full, prompts the pancreas to release insulin in proportion to your blood sugar, and slows gastric emptying so food moves from the stomach to the small intestine more gradually. Semaglutide is a synthetic version of this hormone, engineered to stay active in the body for roughly a week rather than the few minutes natural GLP-1 lasts.

The practical result is that appetite changes throughout the day, not just at mealtimes. Many people find that portion sizes they previously considered small now feel adequate, and the pull towards high-calorie foods (what researchers call hedonic eating) reduces. If you want to understand how semaglutides help you lose weight by reshaping these hunger signals rather than simply switching them off, our dedicated page explains the process in detail. It is not a simple suppression of hunger; it is a recalibration of the signals the brain uses to decide when enough is enough.

The NHS medicines page for semaglutide explains this mechanism in patient-friendly terms and is a reliable first stop for anyone wanting a clear summary outside of clinical papers. For a closer look at how the chemistry translates to weight change, our page on semaglutide's chemistry goes further into the molecular detail.

What this means in practice: titration, tolerance and realistic timelines

Semaglutide does not work at full dose from day one. Treatment starts low (0.25mg weekly for the injection) and steps up roughly every four weeks, guided by the prescriber, until the maintenance dose of 2.4mg (or, for some patients, 7.2mg following the MHRA's April 2026 approval of a higher-dose pen) is reached. That titration period exists because the gastrointestinal side effects (nausea, occasional vomiting, loose stools) are dose-dependent and manageable when the dose climbs gradually. Rushing it tends to make side effects worse without improving outcomes.

Appetite changes are often noticeable within the first few weeks, but meaningful weight loss typically builds over several months. Patients in STEP 1 were still losing weight at week 68; most of the benefit accumulates steadily rather than arriving all at once. That timeline matters when people are weighing up whether to start. If you are curious whether this treatment is likely to help in your specific situation, our page on whether semaglutide will help you lose weight walks through the factors that predict response.

Since June 2026, a once-daily oral tablet (Wegovy tablets, 25mg maintenance dose) is also licensed in the UK, the first oral GLP-1 for weight management. Taken on an empty stomach first thing, before the kettle goes on and at least 30 minutes before any food or drink, it suits patients who prefer not to inject. The Wegovy overview covers both formulations and how the doses compare. Cost context, including what private treatment typically includes beyond the pen price, is covered on the Wegovy pricing page.

These are prescription-only medicines. A prescriber reviews the full clinical picture (not just BMI) before any treatment is issued. Check your eligibility and speak to our prescribers through a free consultation.